{"DataElement":{"publicId":"6543089","version":"1","preferredName":"iRECIST Assessment Discontinuation Reason","preferredDefinition":"A reason describing why the collection of iRECIST results was permanently stopped.","longName":"IRECIST_ASSESS_END_RSN","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"6543085","version":"1","preferredName":"iRECIST Assessment Discontinuation","preferredDefinition":"A modification of the Response Evaluation Criteria in Solid Tumors (RECIST), version 1.1, for use as a standard approach to solid tumor measurements and definitions for objective change in tumor size in cancer clinical trials in which an immunotherapy is used._The final result of a determination of the value, significance, or extent of._To stop or end, permanently or temporarily.","longName":"6543082v1.0:6543083v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"6543082","version":"1","preferredName":"Immune-Modified Response Evaluation Criteria in Solid Tumors","preferredDefinition":"A modification of the Response Evaluation Criteria in Solid Tumors (RECIST), version 1.1, for use as a standard approach to solid tumor measurements and definitions for objective change in tumor size in cancer clinical trials in which an immunotherapy is used.","longName":"C136711","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immune-Modified Response Evaluation Criteria in Solid Tumors","conceptCode":"C136711","definition":"A modification of the Response Evaluation Criteria in Solid Tumors (RECIST), version 1.1, for use as a standard approach to solid tumor measurements and definitions for objective change in tumor size in cancer clinical trials in which an immunotherapy is used.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"791133C3-F612-5CA6-E053-F662850AB671","latestVersionIndicator":"Yes","beginDate":"2018-10-25","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-10-25","modifiedBy":"ONEDATA","dateModified":"2018-10-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6543083","version":"1","preferredName":"Assessment Discontinue","preferredDefinition":"The final result of a determination of the value, significance, or extent of.:To stop or end, permanently or temporarily.","longName":"C25217:C25484","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Discontinue","conceptCode":"C25484","definition":"To stop or end, permanently or temporarily.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"791133C3-F623-5CA6-E053-F662850AB671","latestVersionIndicator":"Yes","beginDate":"2018-10-25","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-10-25","modifiedBy":"ONEDATA","dateModified":"2018-10-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"iRECIST:  Immune Response Evaluation Criteria in Solid Tumours (RECIST)-2017","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"791133C3-F634-5CA6-E053-F662850AB671","latestVersionIndicator":"Yes","beginDate":"2018-10-25","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-10-25","modifiedBy":"KNABLEJ","dateModified":"2018-10-25","changeDescription":"10/28/18 jk created for EORTC AISBL-IVZW form and RECIST FG content.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6543075","version":"1","preferredName":"iRECIST Assessment Discontinue Reason","preferredDefinition":"A modification of the Response Evaluation Criteria in Solid Tumors (RECIST), version 1.1, for use as a standard approach to solid tumor measurements and definitions for objective change in tumor size in cancer clinical trials in which an immunotherapy is used._The final result of a determination of the value, significance, or extent of._To stop or end, permanently or temporarily._An explanation of the cause of some phenomenon or action.","longName":"6543075v1.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"40","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Patient's decision","valueDescription":"Patient Decision","ValueMeaning":{"publicId":"6028404","version":"1","preferredName":"Patient Decision","longName":"6028404","preferredDefinition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.: A position, opinion, or judgment reached on an issue under consideration.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Patient","conceptCode":"C16960","definition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Decision","conceptCode":"C53285","definition":"A position, opinion, or judgment reached on an issue under consideration.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5E0739D8-B27C-223E-E053-F662850A0DF2","latestVersionIndicator":"Yes","beginDate":"2017-11-15","endDate":null,"createdBy":"MAESKEB","dateCreated":"2017-11-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"790E28F8-2A79-5CAA-E053-F662850A7407","beginDate":"2018-10-25","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-10-25","modifiedBy":"ONEDATA","dateModified":"2018-10-25","deletedIndicator":"No"},{"value":"iCPD never occurred","valueDescription":"iRECIST Confirmed Progressive Disease Never Occurrence","ValueMeaning":{"publicId":"6543076","version":"1","preferredName":"iRECIST Confirmed Progressive Disease Never Occurrence","longName":"6543076","preferredDefinition":"Radiographic progression which has been confirmed by additional imaging showing worsening of initial progression.: Not ever; at no time in the past (or future).: An instance of something happening, such as an event or incident.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"iRECIST Confirmed Progressive Disease","conceptCode":"C142356","definition":"Radiographic progression which has been confirmed by additional imaging showing worsening of initial progression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Never","conceptCode":"C70543","definition":"Not ever; at no time in the past (or future).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Occurrence","conceptCode":"C25275","definition":"An instance of something happening, such as an event or incident.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"790E28F8-2A88-5CAA-E053-F662850A7407","latestVersionIndicator":"Yes","beginDate":"2018-10-25","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-10-25","modifiedBy":"ONEDATA","dateModified":"2018-10-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"790E28F8-2AA1-5CAA-E053-F662850A7407","beginDate":"2018-10-25","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-10-25","modifiedBy":"ONEDATA","dateModified":"2018-10-25","deletedIndicator":"No"},{"value":"Subject not clinically stable","valueDescription":"Study Subject Negation Clinical Stable","ValueMeaning":{"publicId":"6543077","version":"1","preferredName":"Study Subject Negation Clinical Stable","longName":"6543077","preferredDefinition":"A matter or an individual that is observed, analyzed, examined, investigated, experimented upon, or/and treated in the course of a particular study.: An operation in which a term denies or inverts the meaning of another term or construction.: Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.: Subject to little fluctuation; showing little if any change.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Study Subject","conceptCode":"C41189","definition":"A matter or an individual that is observed, analyzed, examined, investigated, experimented upon, or/and treated in the course of a particular study.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Stable","conceptCode":"C30103","definition":"Subject to little fluctuation; showing little if any change.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"790E28F8-2AB0-5CAA-E053-F662850A7407","latestVersionIndicator":"Yes","beginDate":"2018-10-25","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-10-25","modifiedBy":"ONEDATA","dateModified":"2018-10-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"790E28F8-2AC9-5CAA-E053-F662850A7407","beginDate":"2018-10-25","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-10-25","modifiedBy":"ONEDATA","dateModified":"2018-10-25","deletedIndicator":"No"},{"value":"Study treatment discontinuation","valueDescription":"Treatment Study Discontinue","ValueMeaning":{"publicId":"6543078","version":"1","preferredName":"Treatment Study Discontinue","longName":"6543078","preferredDefinition":"A type of study protocol designed to evaluate intervention(s) for disease treatment.: To stop or end, permanently or temporarily.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Treatment Study","conceptCode":"C49656","definition":"A type of study protocol designed to evaluate intervention(s) for disease treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Discontinue","conceptCode":"C25484","definition":"To stop or end, permanently or temporarily.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"790E28F8-2AD6-5CAA-E053-F662850A7407","latestVersionIndicator":"Yes","beginDate":"2018-10-25","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-10-25","modifiedBy":"ONEDATA","dateModified":"2018-10-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"790E28F8-2AEF-5CAA-E053-F662850A7407","beginDate":"2018-10-25","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-10-25","modifiedBy":"ONEDATA","dateModified":"2018-10-25","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2559653","version":"1","preferredName":"Other","longName":"2559653","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B612-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"GDEEN","dateModified":"2023-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"790E28F8-2AF9-5CAA-E053-F662850A7407","beginDate":"2018-01-19","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-10-25","modifiedBy":"ONEDATA","dateModified":"2018-10-25","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6543074","version":"1","preferredName":"Immune-Modified Response Evaluation Criteria in Solid Tumors Assessment Discontinue Reason","preferredDefinition":"A modification of the Response Evaluation Criteria in Solid Tumors (RECIST), version 1.1, for use as a standard approach to solid tumor measurements and definitions for objective change in tumor size in cancer clinical trials in which an immunotherapy is used.:The final result of a determination of the value, significance, or extent of.:To stop or end, permanently or temporarily.:An explanation of the cause of some phenomenon or action.","longName":"C136711:C25217:C25484:C25638","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immune-Modified Response Evaluation Criteria in Solid Tumors","conceptCode":"C136711","definition":"A modification of the Response Evaluation Criteria in Solid Tumors (RECIST), version 1.1, for use as a standard approach to solid tumor measurements and definitions for objective change in tumor size in cancer clinical trials in which an immunotherapy is used.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Discontinue","conceptCode":"C25484","definition":"To stop or end, permanently or temporarily.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Reason","conceptCode":"C25638","definition":"An explanation of the cause of some phenomenon or action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"790E28F8-2A47-5CAA-E053-F662850A7407","latestVersionIndicator":"Yes","beginDate":"2018-10-25","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-10-25","modifiedBy":"ONEDATA","dateModified":"2018-10-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"iRECIST:  Immune Response Evaluation Criteria in Solid Tumours (RECIST)-2017","workflowStatus":"RELEASED","registrationStatus":"Application","id":"790E28F8-2A58-5CAA-E053-F662850A7407","latestVersionIndicator":"Yes","beginDate":"2018-10-25","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-10-25","modifiedBy":"KNABLEJ","dateModified":"2018-10-25","changeDescription":"10/25/18 jk created for EORTC AISBL-IVZW iRECIST CRF template; check EORTC to add PVs.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5635300","version":"1","longName":"Case Report Form (CRF) Modules","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"5635324","version":"1","longName":"RECIST","context":"NCI Standards"},{"publicId":"6006601","version":"1","longName":"iRECIST","context":"NCI Standards"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Reason for iRECIST assessment","type":"Preferred Question Text","description":"Reason for iRECIST assessment discontinuation","url":null,"context":"NCI Standards"}],"origin":"iRECIST:  Immune Response Evaluation Criteria in Solid Tumours (RECIST)-2017","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"790E84EF-09C5-472A-E053-F662850AE0D0","latestVersionIndicator":"Yes","beginDate":"2018-10-25","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-10-25","modifiedBy":"KNABLEJ","dateModified":"2018-10-25","changeDescription":"10/25/18 jk created for EORTC AISBL-IVZW form and iRECIST FG content finalization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}